$DORM
Dorman Products, Inc.

2014 Form 10-K Financial Statement

#000119312515061893 Filed on February 25, 2015

View on sec.gov

Income Statement

Concept 2014 2013 Q4 2013 Q3
Revenue $751.5M $169.8M $178.0M
YoY Change 13.09% 25.77% 13.77%
Cost Of Revenue $464.3M $103.7M $108.2M
YoY Change 15.06% 24.64% 11.98%
Gross Profit $287.2M $66.10M $69.70M
YoY Change 10.05% 27.61% 16.67%
Gross Profit Margin 38.22% 38.93% 39.17%
Selling, General & Admin $146.5M $34.50M $34.03M
YoY Change 10.1% 19.38% 18.94%
% of Gross Profit 51.0% 52.19% 48.83%
Research & Development $15.80M
YoY Change 17.91%
% of Gross Profit 5.5%
Depreciation & Amortization $12.66M $2.800M $2.700M
YoY Change 24.6% 27.27% 35.0%
% of Gross Profit 4.41% 4.24% 3.87%
Operating Expenses $162.3M $34.50M $34.03M
YoY Change 10.82% 19.79% 18.94%
Operating Profit $140.7M $31.61M $35.67M
YoY Change 10.0% 37.63% 14.58%
Interest Expense $204.0K $0.00 $47.00K
YoY Change 7.94% 23.68%
% of Operating Profit 0.14% 0.0% 0.13%
Other Income/Expense, Net
YoY Change
Pretax Income $140.5M $31.60M $35.62M
YoY Change 10.0% 37.99% 14.57%
Income Tax $50.54M $10.90M $12.74M
% Of Pretax Income 35.97% 34.49% 35.75%
Net Earnings $89.99M $20.62M $22.89M
YoY Change 9.85% 34.76% 12.51%
Net Earnings / Revenue 11.97% 12.14% 12.86%
Basic Earnings Per Share $2.50 $0.63
Diluted Earnings Per Share $2.49 $0.56 $0.62
COMMON SHARES
Basic Shares Outstanding 36.05M shares 36.48M shares 36.36M shares
Diluted Shares Outstanding 36.19M shares 36.63M shares

Balance Sheet

Concept 2014 2013 Q4 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $47.70M $60.60M $48.30M
YoY Change -21.29% 118.77% -26.93%
Cash & Equivalents $47.70M $60.59M $48.34M
Short-Term Investments
Other Short-Term Assets $3.100M $26.70M $22.90M
YoY Change -88.39% 16.59% 2.23%
Inventory $173.5M $160.4M $149.1M
Prepaid Expenses
Receivables $206.0M $180.8M $178.7M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $430.4M $428.4M $399.0M
YoY Change 0.47% 27.48% 9.83%
LONG-TERM ASSETS
Property, Plant & Equipment $82.30M $64.79M $58.72M
YoY Change 27.01% 32.87% 23.88%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $15.10M $5.888M $1.734M
YoY Change 155.93% 345.05% 23.86%
Total Long-Term Assets $127.3M $100.8M $90.57M
YoY Change 26.29% 31.49% 20.11%
TOTAL ASSETS
Total Short-Term Assets $430.4M $428.4M $399.0M
Total Long-Term Assets $127.3M $100.8M $90.57M
Total Assets $557.7M $529.2M $489.6M
YoY Change 5.39% 28.23% 11.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $59.50M $61.26M $49.14M
YoY Change -2.94% 44.51% 26.97%
Accrued Expenses $31.30M $18.70M $20.61M
YoY Change 2.62% 63.28% 58.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $90.80M $91.74M $77.79M
YoY Change -0.98% 44.05% 50.46%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.800M $5.310M $5.779M
YoY Change -9.43% 54.05% 86.42%
Total Long-Term Liabilities $4.800M $5.310M $5.779M
YoY Change -9.43% 54.05% 86.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $90.80M $91.74M $77.79M
Total Long-Term Liabilities $4.800M $5.310M $5.779M
Total Liabilities $95.70M $97.05M $83.57M
YoY Change -17.14% 44.56% 26.05%
SHAREHOLDERS EQUITY
Retained Earnings $370.2M $350.3M
YoY Change 26.98%
Common Stock $365.0K $365.0K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $462.1M $413.6M $393.6M
YoY Change
Total Liabilities & Shareholders Equity $557.7M $529.2M $489.6M
YoY Change 5.39% 28.23% 11.6%

Cashflow Statement

Concept 2014 2013 Q4 2013 Q3
OPERATING ACTIVITIES
Net Income $89.99M $20.62M $22.89M
YoY Change 9.85% 34.76% 12.51%
Depreciation, Depletion And Amortization $12.66M $2.800M $2.700M
YoY Change 24.6% 27.27% 35.0%
Cash From Operating Activities $59.64M $24.80M $15.50M
YoY Change -3.12% 22.17% 198.08%
INVESTING ACTIVITIES
Capital Expenditures $29.86M -$11.80M -$5.800M
YoY Change 21.07% 218.92% 18.37%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$29.86M -$11.80M -$5.800M
YoY Change 12.42% 218.92% 18.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -42.72M -700.0K -1.100M
YoY Change 1923.45% -98.73% -320.0%
NET CHANGE
Cash From Operating Activities 59.64M 24.80M 15.50M
Cash From Investing Activities -29.86M -11.80M -5.800M
Cash From Financing Activities -42.72M -700.0K -1.100M
Net Change In Cash -12.94M 12.30M 8.600M
YoY Change -139.34% -132.03% 975.0%
FREE CASH FLOW
Cash From Operating Activities $59.64M $24.80M $15.50M
Capital Expenditures $29.86M -$11.80M -$5.800M
Free Cash Flow $29.78M $36.60M $21.30M
YoY Change -19.29% 52.5% 110.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
18.02
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.62
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
174154 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
274000 shares
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
332872000
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1785000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27708000
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
1400000
CY2013Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1800000
CY2013Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
1900000
CY2013Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
3700000
CY2013Q2 dorm Goodwill And Other Intangible Assets Acquired
GoodwillAndOtherIntangibleAssetsAcquired
3600000
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36464958 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36464958 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
24.47
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.13
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
109459 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
141500 shares
CY2013Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
100000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
78441000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
91738000
CY2013Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
9343000
CY2013Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
484000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
365000
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
21281000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5851000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
61255000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
370157000
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
18480000
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18704000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
413641000
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5310000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
529169000
CY2013Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
18963000
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
43119000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1201000
CY2013Q4 us-gaap Line Of Credit
LineOfCredit
0
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11779000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60593000
CY2013Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
59881000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
64786000
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
417000
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
97382000
CY2013Q4 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
3124000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
143227000
CY2013Q4 us-gaap Assets
Assets
529169000
CY2013Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
6546000
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
2318000
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
20798000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
1928000
CY2013Q4 us-gaap Inventory Net
InventoryNet
160387000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
180777000
CY2013Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
30089000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5888000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
428406000
CY2013Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
4000000
CY2013Q4 dorm Number Of Foreign Forward Contracts Outstanding
NumberOfForeignForwardContractsOutstanding
0 Contract
CY2013Q4 dorm Number Of Largest Customer
NumberOfLargestCustomer
5 Customer
CY2013Q4 dorm Accrued Customer Rebates
AccruedCustomerRebates
13700000
CY2013Q4 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
65879000
CY2013Q4 dorm Deferred Tax Assets Accounts Receivable
DeferredTaxAssetsAccountsReceivable
12390000
CY2013Q4 dorm Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
9136000
CY2013Q4 dorm Entity Wide Receivable Five Largest Customers Percentage
EntityWideReceivableFiveLargestCustomersPercentage
0.81 pure
CY2013Q4 dorm Receivables Not Sold Additional Receivables Outstanding
ReceivablesNotSoldAdditionalReceivablesOutstanding
267800000
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35611238 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35611238 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
27.82
CY2014Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
6.95
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q4 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.0092 pure
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.28
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
73000 shares
CY2014Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
7.28
CY2014Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
73000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2000000 shares
CY2014Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
50000000 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
72900 shares
CY2014Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
75000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1719766 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
75000 shares
CY2014Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
100000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
82855000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
0
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
90833000
CY2014Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
9761000
CY2014Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
900000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
356000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
59541000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
418292000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1625000
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
22652000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20579000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
462061000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4822000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
12918000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
72000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
3691000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
580368000
CY2014Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
23167000
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
43413000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1163000
CY2014Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
200000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3702000
CY2014Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
30000000
CY2014Q4 us-gaap Line Of Credit
LineOfCredit
0
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10713000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
3828000
CY2014Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
29000000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47656000
CY2014Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
65603000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
82270000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3119000
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
25618000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3147000
CY2014Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
197000
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
105117000
CY2014Q4 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
2803000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
165125000
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3060000
CY2014Q4 us-gaap Assets
Assets
580368000
CY2014Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
7989000
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
2451000
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
25103000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
1780000
CY2014Q4 us-gaap Inventory Net
InventoryNet
173523000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
206035000
CY2014Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
29989000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12645000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
455464000
CY2014Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
10200000
CY2014Q4 dorm Number Of Foreign Forward Contracts Outstanding
NumberOfForeignForwardContractsOutstanding
0 Contract
CY2014Q4 dorm Number Of Largest Customer
NumberOfLargestCustomer
5 Customer
CY2014Q4 dorm Number Of Common Stock Held Under Retirement Plan
NumberOfCommonStockHeldUnderRetirementPlan
361138 shares
CY2014Q4 dorm Accrued Customer Rebates
AccruedCustomerRebates
14300000
CY2014Q4 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
79179000
CY2014Q4 dorm Deferred Tax Assets Accounts Receivable
DeferredTaxAssetsAccountsReceivable
15652000
CY2014Q4 dorm Common Stock Held By Relatives Of Director Percentage
CommonStockHeldByRelativesOfDirectorPercentage
0.24 pure
CY2014Q4 dorm Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
13406000
CY2014Q4 dorm Entity Wide Receivable Five Largest Customers Percentage
EntityWideReceivableFiveLargestCustomersPercentage
0.81 pure
CY2014Q4 dorm Receivables Not Sold Additional Receivables Outstanding
ReceivablesNotSoldAdditionalReceivablesOutstanding
298900000
CY2014Q4 dorm Number Of Outstanding Letters Of Credit
NumberOfOutstandingLettersOfCredit
2 LetterOfCredit
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
35616334 shares
CY2014Q2 dei Entity Public Float
EntityPublicFloat
1364609466
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
17.12
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.46
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
204800 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
692800 shares
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
317103000
CY2011Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2161000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50196000
CY2012Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.50
CY2012 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.94
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.27
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.362 pure
CY2012 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
370000 shares
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
48911000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
26.70
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
45646 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y8M12D
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.017 pure
CY2012 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.82
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
20000 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
15000 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.002 pure
CY2012 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.12
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
16.84
CY2012 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36494000 shares
CY2012 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.96
CY2012 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.84
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
22.71
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.003 pure
CY2012 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.12
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.59 pure
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20000 shares
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
438800 shares
CY2012 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36124000 shares
CY2012 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2012 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2810000
CY2012 us-gaap Gross Profit
GrossProfit
215209000
CY2012 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
35329000
CY2012 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1606000
CY2012 us-gaap Payments Of Dividends
PaymentsOfDividends
54716000
CY2012 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
4557000
CY2012 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
1663000
CY2012 us-gaap Sales Revenue Net
SalesRevenueNet
570420000
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-293000
CY2012 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
801000
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
28748000
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
104231000
CY2012 us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
4400000
CY2012 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2987000
CY2012 us-gaap Disposal Group Including Discontinued Operation Foreign Currency Translation Gains Losses
DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses
3000000
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
68152000
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
104108000
CY2012 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
2907000
CY2012 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
3203000
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
698000
CY2012 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
66405000
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18078000
CY2012 us-gaap Net Income Loss
NetIncomeLoss
70962000
CY2012 us-gaap Interest Paid
InterestPaid
219000
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9730000
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1007000
CY2012 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2384000
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8225000
CY2012 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
69000
CY2012 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2070000
CY2012 us-gaap Interest Expense
InterestExpense
123000
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10500000
CY2012 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
110978000
CY2012 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
379000
CY2012 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-170000
CY2012 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
266000
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-22488000
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
37703000
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18078000
CY2012 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1500000
CY2012 us-gaap Restricted Stock Expense
RestrictedStockExpense
800000
CY2012 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
37192000
CY2012 us-gaap Cost Of Goods Sold
CostOfGoodsSold
355211000
CY2012 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
312700000
CY2012 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
200000
CY2012 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2895000
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-53390000
CY2012 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
2000000
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1606000
CY2012 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
40087000
CY2012 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
3500000
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
1007000
CY2012 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-2214000
CY2012 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
1400000
CY2012 us-gaap Dividends Common Stock
DividendsCommonStock
54716000
CY2012 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
10738000
CY2012 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
1943000
CY2012 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
651000
CY2012 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
44000
CY2012 dorm Other Stock Related Activity
OtherStockRelatedActivity
1663000
CY2012 dorm Entity Wide Revenue Major Customer Aggregate Percentage
EntityWideRevenueMajorCustomerAggregatePercentage
0.57 pure
CY2012 dorm Export Sales
ExportSales
23500000
CY2012 dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
1943000
CY2012 dorm Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Option Price Per Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodOptionPricePerShare
22.71
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.24
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
43126 shares
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.21
CY2013 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
78580 shares
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.359 pure
CY2013 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
277000 shares
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
61559000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
45.06
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
47069 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
36000 shares
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.016 pure
CY2013 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
2.24
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
25500 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
17.38
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
16.98
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
18.28
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36624000 shares
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.25
CY2013 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.25
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.007 pure
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
96500 shares
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36347000 shares
CY2013 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2013 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
1897000
CY2013 us-gaap Gross Profit
GrossProfit
260968000
CY2013 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
44291000
CY2013 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
551000
CY2013 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
827000
CY2013 us-gaap Sales Revenue Net
SalesRevenueNet
664466000
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-840000
CY2013 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
884000
CY2013 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
30000
CY2013 dorm Other Stock Related Activity
OtherStockRelatedActivity
827000
CY2013 dorm Entity Wide Revenue Major Customer Aggregate Percentage
EntityWideRevenueMajorCustomerAggregatePercentage
0.57 pure
CY2013 dorm Export Sales
ExportSales
33200000
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
18537000
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
127939000
CY2013 us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
5200000
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
81920000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
127750000
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
453000
CY2013 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
81920000
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24666000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
81920000
CY2013 us-gaap Interest Paid
InterestPaid
201000
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
40791000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
960000
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
267000
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10159000
CY2013 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
9804000
CY2013 us-gaap Interest Expense
InterestExpense
189000
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13400000
CY2013 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
133029000
CY2013 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
271000
CY2013 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
18000
CY2013 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
194000
CY2013 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
3500000
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
32885000
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45830000
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26563000
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1500000
CY2013 us-gaap Restricted Stock Expense
RestrictedStockExpense
800000
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
42458000
CY2013 us-gaap Cost Of Goods Sold
CostOfGoodsSold
403498000
CY2013 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
406400000
CY2013 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
100000
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3105000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2111000
CY2013 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
1900000
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
551000
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
45563000
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
3700000
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
960000
CY2013 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
249000
CY2013 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
17627000
CY2013 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
3489000
CY2013 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
736000
CY2013 dorm Stock Repurchased And Retired During Period Average Purchase Price
StockRepurchasedAndRetiredDuringPeriodAveragePurchasePrice
44.39
CY2013 dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
3489000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
21287 shares
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.97
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Entity Registrant Name
EntityRegistrantName
Dorman Products, Inc.
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.49
CY2014 dei Trading Symbol
TradingSymbol
DORM
CY2014 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
61830 shares
CY2014 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2012-12-05
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.360 pure
CY2014 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
138000 shares
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
59640000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
51.41
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
41619 shares
CY2014 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2012-12-28
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.012 pure
CY2014 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
2.49
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
26347 shares
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 13%"> <b>Use of Estimates in the Preparation of Financial Statements</b>. The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> </div>
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-12-27
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-27
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36190000 shares
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.50
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
23.44
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y6M
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.002 pure
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0000868780
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
48.29
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.50
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.004 pure
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y6M
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5000 shares
CY2014 us-gaap Business Acquisition Effective Date Of Acquisition1
BusinessAcquisitionEffectiveDateOfAcquisition1
2013-05-17
CY2014 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 13%"> <b>Concentrations of Risk</b>. Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents and accounts receivable. All cash equivalents are managed within established guidelines which limit the amount which may be invested with one issuer. A significant percentage of our accounts receivable have been, and will continue to be, concentrated among a relatively small number of automotive retailers and warehouse distributors in the United States. Our five largest customers accounted for 81% of net accounts receivable as of December&#xA0;27, 2014 and December&#xA0;28, 2013. We continually monitor the credit terms and credit limits to these and other customers. In fiscal 2014, approximately 73% of our products were purchased from suppliers located in a variety of foreign countries, with the largest portion coming from China.</p> </div>
CY2014 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2012-12-17
CY2014 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2017-12-31
CY2014 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 13%"> <b>Reclassifications</b>. Certain prior year amounts have been reclassified to conform with current-year presentation.</p> </div>
CY2014 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y6M
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
66500 shares
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36052000 shares
CY2014 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2014 us-gaap Gross Profit
GrossProfit
287201000
CY2014 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
46540000
CY2014 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
463000
CY2014 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
343000
CY2014 us-gaap Sales Revenue Net
SalesRevenueNet
751476000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
522000
CY2014 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
6757000
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13136000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
140734000
CY2014 us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
6200000
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
89987000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
140530000
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
301000
CY2014 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
89987000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29862000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
89987000
CY2014 us-gaap Interest Paid
InterestPaid
234000
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
25566000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1146000
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-632000
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12658000
CY2014 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
3712000
CY2014 us-gaap Interest Expense
InterestExpense
204000
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15800000
CY2014 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
146467000
CY2014 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1000000
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-35000
CY2014 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
308000
CY2014 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
3100000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-12937000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
50543000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29862000
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1500000
CY2014 us-gaap Restricted Stock Expense
RestrictedStockExpense
1100000
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
48293000
CY2014 us-gaap Cost Of Goods Sold
CostOfGoodsSold
464275000
CY2014 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
477900000
CY2014 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
100000
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2882000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-42715000
CY2014 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
2500000
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
463000
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
51175000
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
4100000
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
1146000
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-597000
CY2014 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1558000
CY2014 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
43519000
CY2014 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
38000
CY2014 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
301000
CY2014 dorm Other Stock Related Activity
OtherStockRelatedActivity
343000
CY2014 dorm Percentage Of Product Purchased From Supplier In Foreign Country
PercentageOfProductPurchasedFromSupplierInForeignCountry
0.73 pure
CY2014 dorm Entity Wide Revenue Major Customer Aggregate Percentage
EntityWideRevenueMajorCustomerAggregatePercentage
0.60 pure
CY2014 dorm Short Term Investment Original Maturity Period Description
ShortTermInvestmentOriginalMaturityPeriodDescription
Three months or less
CY2014 dorm Number Of Largest Customers
NumberOfLargestCustomers
4 Customer
CY2014 dorm Line Of Credit Facility Expiration Month And Year
LineOfCreditFacilityExpirationMonthAndYear
2015-06
CY2014 dorm Maximum Grant Period From Date Of Plan Approval
MaximumGrantPeriodFromDateOfPlanApproval
P10Y
CY2014 dorm Export Sales
ExportSales
39100000
CY2014 dorm Stock Repurchased And Retired During Period Average Purchase Price
StockRepurchasedAndRetiredDuringPeriodAveragePurchasePrice
50.71
CY2014 dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
43521000
CY2014 dorm Date Of Plan Approval
DateOfPlanApproval
2009-05-20
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2013Q4 us-gaap Sales Revenue Net
SalesRevenueNet
169809000
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
31607000
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
20619000
CY2014Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2014Q4 us-gaap Sales Revenue Net
SalesRevenueNet
173981000
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
28611000
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
18656000
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2013Q1 us-gaap Sales Revenue Net
SalesRevenueNet
154443000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
29908000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
19072000
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.53
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
162261000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
30754000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
19342000
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
177953000
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
35670000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
22887000
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.64
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
183512000
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
36947000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
23551000
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.64
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
196187000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
36700000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
23244000
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.68
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
197796000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
38476000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
24536000

Files In Submission

Name View Source Status
0001193125-15-061893-index-headers.html Edgar Link pending
0001193125-15-061893-index.html Edgar Link pending
0001193125-15-061893.txt Edgar Link pending
0001193125-15-061893-xbrl.zip Edgar Link pending
d845977d10k.htm Edgar Link pending
d845977dex21.htm Edgar Link pending
d845977dex23.htm Edgar Link pending
d845977dex311.htm Edgar Link pending
d845977dex312.htm Edgar Link pending
d845977dex32.htm Edgar Link pending
dorm-20141227.xml Edgar Link completed
dorm-20141227.xsd Edgar Link pending
dorm-20141227_cal.xml Edgar Link unprocessable
dorm-20141227_def.xml Edgar Link unprocessable
dorm-20141227_lab.xml Edgar Link unprocessable
dorm-20141227_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g845977g96l89.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending